Back to company

Speciallægeselskabet Hudklinikken Esbjerg ApS: Financial statements 2024

CVR: 44152789

Speciallægeselskabet Hudklinikken Esbjerg ApS (CVR 44152789) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 4,687,145 and a net result of DKK 807,242 compared with DKK 271,129 the year before. That is a decrease of 1% compared with the year before. Equity amounted to DKK 5,427,076. The solvency ratio was 86.2%. The company had 4 employees in the financial year.

Gross Profit
4,687,145 kr.
Profit/Loss
807,242 kr.
Equity
5,427,076 kr.
Total Assets
6,298,459 kr.
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-4.7 mio.807 t.5.4 mio.4
2023-4.7 mio.271 t.4.6 mio.4

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Speciallægeselskabet Hudklinikken Esbjerg ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

Speciallægeselskabet Hudklinikken Esbjerg ApS: The 2023 annual report is outMay 23, 2024

Speciallægeselskabet Hudklinikken Esbjerg ApS has published its annual report for 2023. Gross profit came to DKK 4,735,461, and the net result was DKK 271,129.

About Speciallægeselskabet Hudklinikken Esbjerg ApS

Speciallægeselskabet Hudklinikken Esbjerg ApS is a Danish company of the type Anpartsselskab based in Esbjerg, founded in 2023. The company is registered under the industry Speciallægers aktiviteter. The management consists of Søren Frankild. The company is owned by Speciallægeholdingselskabet Hudklinikken Esbjerg ApS. In 2025, the company reported a gross profit of DKK 4,988,140 and a net result of DKK 705,122 compared with DKK 807,242 the year before. Equity amounted to DKK 6,132,198.

Other financial years